The Venture Codex Logo

The Venture Codex

Overview

Venture capital firm investing in early-stage life sciences companies.

Founded

2019

Deals ยท 12mo

1

Stage focus

Series A
Series B

Geographic focus

Japan
United States

Sector focus

Biotechnology
Life Science
Pharmaceutical

Investment portfolio

9rounds
NAMEDATESIZE
Crystalys Therapeutics
Jul 2026Participated
$130 MSeries B
Crystalys Therapeutics
Sep 2025Led
$205 MSeries A
Pathalys Pharma
Aug 2024Participated
$105 MSeries B
Renalys Pharma
Jul 2024Led
$38 MSeries A
Arialys Therapeutics
Sep 2023Participated
$58 MSeed
Pathalys Pharma
Jan 2023Participated
$150 MOther Equity
Mineralys Therapeutics
Jun 2022Participated
$118 MSeries B
HilleVax
Sep 2021Participated
$135 MOther Equity
Mineralys Therapeutics
Apr 2021Participated
$40 MSeries A
Crystalys Therapeutics
Jul 2026Participated
$130 MSeries B
Crystalys Therapeutics
Sep 2025Led
$205 MSeries A
Pathalys Pharma
Aug 2024Participated
$105 MSeries B
Renalys Pharma
Jul 2024Led
$38 MSeries A
Arialys Therapeutics
Sep 2023Participated
$58 MSeed
Pathalys Pharma
Jan 2023Participated
$150 MOther Equity
Mineralys Therapeutics
Jun 2022Participated
$118 MSeries B
HilleVax
Sep 2021Participated
$135 MOther Equity
Mineralys Therapeutics
Apr 2021Participated
$40 MSeries A
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Catalys Pacific: 9 funding rounds are recorded in the selected participation categories.All available history.
Catalys Pacific: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A21
Series B03
Other Equity02

Monthly Deal Activity

Catalys Pacific: 9 deals are recorded across 67 months.All available history.
Catalys Pacific: 9 deals are recorded across 67 months. All available history
MonthDeals
Apr '211
May '210
Jun '210
Jul '210
Aug '210
Sep '211
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '231
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '241
Aug '241
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '251
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '261
Aug '260
Sep '260
Oct '260

Sector Breakdown

Catalys Pacific: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Catalys Pacific: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9

Deal Size Distribution

Catalys Pacific: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Catalys Pacific: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M2
$50M-$100M1
$100M-$250M6
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Catalys Pacific: United States has the largest recorded deal count among the displayed regions (8 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Catalys Pacific: United States has the largest recorded deal count among the displayed regions (8 deals). All available history
RegionDeals
United States8
Japan1
Catalys Pacific: 20 co-investors are shown, with Samsara BioCapital sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Catalys Pacific: Led accounts for 22% and participating for 78% of round participation.All available history.
Catalys Pacific: Led accounts for 22% and participating for 78% of round participation. All available history
CategoryDeals (count)Share (%)
Led222%
Participating778%
Catalys Pacific: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Catalys Pacific: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led2100%

Team

Ashwin Ram

Vice President

BT Slingsby

Founder & Managing Partner

Hiromi Miwa

Junior Associate

Maki Haginoya

Junior Associate

Reika Okada

Associate

Takeshi Takahashi

Managing Partner